Ipca Laboratories has acquired Onyx Scientific, a chemistry solutions provider, which will continue to operate out of its Sunderland, UK facility as Onyx Scientific. Onyx Scientific’s chemistry capabilities for medicinal, preclinical and Phase I/II programs adds to Ipca’s capabilities supporting Phase II to commercial scale programs. Tony Flinn, chief executive officer at Onyx, said, “The combined entity of Onyx Scientific and the Covenance division of Ipca will offer customers comprehensive so...